MARKET

NVOS

NVOS

Novo Integrated Sciences Inc
NASDAQ
0.4664
-0.0435
-8.53%
After Hours: 0.4636 -0.0028 -0.60% 19:43 04/18 EDT
OPEN
0.5020
PREV CLOSE
0.5099
HIGH
0.5100
LOW
0.4600
VOLUME
564.58K
TURNOVER
0
52 WEEK HIGH
5.38
52 WEEK LOW
0.4300
MARKET CAP
8.89M
P/E (TTM)
-0.3958
1D
5D
1M
3M
1Y
5Y
NVOS Stock Earnings: Novo Integrated Sciences Reported Results for Q2 2024
Novo Integrated Sciences reported results for the second quarter of 2024. The company reported earnings per share of -16 cents and revenue of $3.17 million. Novo Integrated Sciences is a biopharmaceutical company that develops drugs for cancer and other diseases. The stock was down 2.7% to $8.05 in the afternoon.
Investorplace · 3d ago
Financial Report Articles: Q2 2023 - Q4 2024
Press release · 3d ago
Novo Integrated Sciences GAAP EPS of -$0.16, revenue of $3.17M
Seeking Alpha · 3d ago
Novo Integrated Sciences Q2 EPS $(0.16) Up From $(0.59) YoY, Sales $3.17M Up From $2.56M YoY
Novo Integrated Sciences reported quarterly losses of $0.16 per share. The company reported $3.17 million in sales this quarter. This is a 72.88 percent increase over sales of $2.56 million in the same period last year. The firm also reported a 24.00 percent increase in sales.
Benzinga · 3d ago
*Novo Integrated Sciences: Continue to Work With Certain Prospective Fincl Partners to Close Previously Announced Non-Traditional Financing Opportunities >NVOS
Dow Jones · 3d ago
*Novo Integrated Sciences 2Q Loss/Shr 16c >NVOS
Dow Jones · 3d ago
*Novo Integrated Sciences 2Q Rev $3.17M >NVOS
Dow Jones · 3d ago
Press Release: Novo Integrated Sciences Reports -4-
Dow Jones · 3d ago
More
About NVOS
Novo Integrated Sciences, Inc. is a parent company to its subsidiaries. The Company owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The Company operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.

Webull offers Novo Integrated Sciences Inc stock information, including NASDAQ: NVOS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVOS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVOS stock methods without spending real money on the virtual paper trading platform.